Morphologic and molecular characterization of renal cell carcinoma in children and young adults

American Journal of Surgical Pathology

Volumn 28, Issue 9, 2004, Pages 1117-1132

  Bruder, Elisabeth ^a   Passera, Oliver ^a   Harms, Dieter ^b   Leuschner, Ivo ^b   Ladanyi, Marc ^c   Argani, Pedram ^d   Eble, John N ^e   Struckmann, Kirsten ^a   Schraml, Peter ^a   Moch, Holger ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF KIEL   (Germany)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Microsatellite instability; Pediatric renal tumors; TFE3; Translocation carcinomas; VHL gene; Wilms tumor

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ASPL GENE; CANCER CLASSIFICATION; CHILD; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; GENE; GENE DELETION; GENE FUSION; GENE MUTATION; GENE OVEREXPRESSION; GENE TRANSLOCATION; GENETIC TRAIT; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; MALE; MOLECULAR BIOLOGY; MORPHOLOGICAL TRAIT; NEUROBLASTOMA; PAPILLARY CARCINOMA; PHENOTYPE; PRCC GENE; TFE3 GENE; VHL GENE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; CARCINOMA, RENAL CELL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE;

EID: 3442875929     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000131558.32412.40     Document Type: Article

References (46)

1. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192.
2. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002;26:1553-1566.
3. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750-761.
4. Arroyo MR, Green DM, Perlman EJ, et al. The spectrum of metanephric adenofibroma and related lesions: clinicopathologic study of 25 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol. 2001;25:433-444.
5. Beckwith JB. Wilms tumors and other renal tumors of childhood. In: Finegold M, ed. Major Problems in Pathology, vol. 18. Pathology of Neoplasia in Children and Adolescents. Philadelphia: Saunders; 1986:313-332.
6. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
7. Brauch H, Weirich G, Brieger J, et al. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation. Cancer Res. 2000;60:1942-1948.
8. Bugert P, Gaul C, Weber K, et al. Specific genetic changes of diagnostic importance in chromophobe carcinomas. Lab Invest. 1997;76:203-208.
9. Campbell C, Kuriyan NP, Rackley RR, et al. Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma. Int J Cancer. 1998;78:182-188.
10. Carpentieri DF, Nichols K, Chou PM, et al. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol. 2002;15:1080-1086.
11. Diakournis E, Sourvinos G, Kiaris H, et al. Genetic instability in renal cell carcinoma. Eur Urol. 1998;33:227-232.
12. Donnelly LF, Rencken IO, Shardell K, et al. Renal cell carcinoma after therapy for neuroblastoma. AJR Am J Roentgenol. 1996;167:915-917.
13. Duffy K, Al-Saleem T, Karbowniczek M, et al. Mutational analysis of the von Hippel Lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients. Mod Pathol. 2002;15:205-210.
14. Eble JN, Sauter G, Epstein JI, et al. eds. Tumors of the kidney. In: WHO Classification of Tumours: Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press, 2004.
15. Fairchild RS, Kyner JL, Hermreck A, et al. Neuroblastoma, pheochromocytoma and renal cell carcinoma: occurrence in a single patient. JAMA. 1979;242:2210-2211.
16. Fenton DS, Taub JW, Amundson GM, et al. Renal cell carcinoma occurring in a child 2 years after chemotherapy for neuroblastoma. AJR Am J Roentgenol. 1993;161:165-166.
17. Fleitz JM, Wootton-Gorges SL, Wyatt Ashmead J, et al. Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood. Pediatr Radiol. 2003;33:540-545.
18. Foster K, Prowse A, van den Berg A, et al. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet. 1994;3:2169-2173.
19. Gessler M, Poustaka A, Cavanee W, et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990;343:774-778.
20. Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet. 1994;7:85-90.
21. Gnarra JR. Von Hippel-Lindau gene mutations in human and rodent renal tumors: association with clear cell phenotype. J Natl Cancer Inst. 1998;90:1685-1687.
22. Hartmann A, Zanardo L, Bocker-Edmonston T, et al. Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res. 2002;62:6796-6802.
23. Jiang F, Richter J, Schraml P, et al. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol. 1998;153:1467-1473.
24. Kageyama Y, Yamamura Y, Oshima H, et al. Infrequent mutations of the WT1 gene in primary cancers of the adult urinary tract. Jpn J Clin Oncol. 1995;25:173-178.
25. Kovacs G, Akhtar M, Beckwith JB, et al. The Heidelberg classification of renal tumours. J Pathol. 1997;183:131-133.
26. Krigman HR, Bentley RC, Strickland DK, et al. Anaplastic renal cell carcinoma following neuroblastoma. Med Pediatr Oncol. 1995;25:52-59.
27. Lack EE, Cassady JR, Sallan SE. Renal cell carcinoma in childhood and adolescence: a clinical and pathological study of 17 cases. J Urol. 1985;133:822-828.
28. Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48-57.
29. Leuschner I, Harms D, Schmidt D. Renal cell carcinoma in children: histology, immunohistochemistry and follow-up of 10 cases. Med Pediatr Oncol. 1991;19:33-41.
30. Medeiros LJ, Palmedo G, Krigmann HR, et al. Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol. 1999;23:772-780.
31. Moch H, Presti JC Jr, Sauter G, et al. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res. 1996;56:27-30.
32. Moch H, Schraml P, Bubendorf L, et al. Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization. Cancer Res. 1998;58:2304-2309.
33. Moch H, Gasser TC, Amin MB, et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000;89:604-614.
34. Muir TE, Cheville JC, Lager DJ. Metanephric adenoma, nephrogenic rests, and Wilms tumor: a histologic and immunophenotypic comparison. Am J Surg Pathol. 2001;25:1290-1296.
35. Murphy WM, Beckwith JB, Farrow GM. Tumors of the Kidney, Bladder and Related Urinary Structures: AFIP Atlas of Tumor Pathology. Washington DC, Armed Forces Institute of Pathology, 1994.
36. Neumann HP, Bender BU, Berger DP, et al. Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol. 1998;16:1248-1254.
37. Oji Y, Miyoshi S, Maeda H, et al. Overexpression of the Wilms tumor gene WT1 in de novo lung cancers. Int J Cancer. 2002;100:297-303.
38. Pritchard-Jones K, Fleming S, Davidson D, et al. The candidate Wilms tumour gene is involved in genitourinary development. Nature. 1990;346:194-197.
39. Pritchard-Jones K, Fleming S. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis. Oncogene. 1991;6:2211-2220.
40. Renshaw AA, Granter SR, Fletcher JA, et al. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol. 1999;23:795-802.
41. Schraml P, Struckmann K, Hatz F, et al. VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J Pathol. 2002;196:186-193.
42. Schraml P, Hergovich A, Hatz F, et al. Relevance of nuclear and cytoplasmic von Hippel Lindau protein expression for renal carcinoma progression. Am J Pathol. 2003;163:1013-1020.
43. Shuin T, Kondo K, Tirigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 1994;54:2852-2855.
44. Speicher MR, Schoell B, du Manoir S, et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol. 1994;145:356-364.
45. Yoshida SO, Imam A. Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas. Cancer Res. 1989;49:1802-1809.
46. Zbar B, Brauch H, Talmadge C, et al. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature. 1987;327:721-727.